EUVIMEDEUVIMED entdecken
Crossref

Targeting Porphyromonas gingivalis virulence and viability with epimedokoreanin B prevents alveolar bone destruction in vivo

Toru Kariu, Keisuke Nakashima, Tsuyoshi Ikeda

Bioscience, Biotechnology, and Biochemistry · 23.07.2026 · 90 (8) · 1064-1071

DOI: 10.1093/bbb/zbag075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, online erschienen am 27.05.2026. Verfasst von Toru Kariu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Shokei University, Chuo-ku, Kumamoto, Japan. Hauptthemen laut MEDLINE: Porphyromonas gingivalis, Alveolar Bone Loss, Flavonoids, Periodontitis. Die Arbeit nennt 21 Literaturangaben. Gefördert von: JSPS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Periodontal disease is a major oral infectious condition that leads to the degradation of alveolar bone and subsequent tooth loss. Porphyromonas gingivalis, a keystone pathogen in periodontitis, plays a critical role in disease initiation and progression. In a previous study, we demonstrated the anti-P. gingivalis activity of epimedokoreanin B, a prenylated flavonoid derived from Epimedium species. However, its in vivo efficacy against periodontitis remains unclear. Oral administration of epimedokoreanin B attenuated P. gingivalis-induced alveolar bone resorption in murine periodontitis models and suppressed infection-induced antibody production. Furthermore, epimedokoreanin B compromised bacterial membrane integrity and virulent gene expressions. In this preclinical study, in vitro and in vivo analyses indicate that epimedokoreanin B suppressed both bacterial viability and virulence, thereby attenuating alveolar bone loss caused by periodontitis. These findings suggest that epimedokoreanin B is a promising candidate for the development of novel therapeutics targeting periodontal pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Porphyromonas gingivalisAlveolar Bone LossFlavonoidsPeriodontitisMicrobial ViabilityAnti-Bacterial AgentsAnimalsVirulenceMice

Stichwörter der Autor:innen

Porphyromonas gingivalisalveolar bone resorptionepimedokoreanin Bperiodontitis

Substanzen

FlavonoidsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Life Science, Shokei University, Chuo-ku, Kumamoto, Japan.
  • Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto, Japan.

Förderung

  • JSPS

Zitieren

APA

Kariu, T., Nakashima, K., & Ikeda, T. (2026). Targeting Porphyromonas gingivalis virulence and viability with epimedokoreanin B prevents alveolar bone destruction in vivo. Bioscience, Biotechnology, and Biochemistry, 90(8), 1064-1071. https://doi.org/10.1093/bbb/zbag075

Vancouver

Kariu T, Nakashima K, Ikeda T. Targeting Porphyromonas gingivalis virulence and viability with epimedokoreanin B prevents alveolar bone destruction in vivo. Bioscience, Biotechnology, and Biochemistry. 2026;90(8):1064-1071. doi:10.1093/bbb/zbag075

BibTeX
@article{Kariu2026,
  author = {Kariu, Toru and Nakashima, Keisuke and Ikeda, Tsuyoshi},
  title = {Targeting Porphyromonas gingivalis virulence and viability with epimedokoreanin B prevents alveolar bone destruction in vivo},
  journal = {Bioscience, Biotechnology, and Biochemistry},
  year = {2026},
  volume = {90},
  number = {8},
  pages = {1064--1071},
  doi = {10.1093/bbb/zbag075}
}
Kostenlos starten →